Twist Bioscience prices $300M stock offering at $96 per share

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…

LTM shares will be in focus after the IT company reported largely in-line Q1FY27 earnings. While revenue growth remained muted, margins beat estimates and brokerages retained a broadly constructive stance. Nomura, Nuvama and Emkay reiterated positive ratings, while JM Financial maintained its ‘Reduce’ call. Analysts see improving deal execution supporting growth, though macro uncertainty and…

The Union Budget for 2026-27 has proposed to treat TReDS receivables as asset-backed securities, aiming to boost liquidity and widen funding options for small businesses.